Healthcare & Life Sciences

Lipidio

Sign in to unlock

About

Lipidio is developing a therapeutic molecule targeting diseases associated with excess body fat, including non-alcoholic steatohepatitis (NASH), Prader-Willi syndrome (PWS), and antipsychotic drug-induced weight gain (AIWG).

Explore Lipidio's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing